Form 8-K - Current report:
SEC Accession No. 0001731122-22-000671
Filing Date
2022-04-05
Accepted
2022-04-05 06:01:29
Documents
13
Period of Report
2022-04-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e3674_8-k.htm   iXBRL 8-K 21843
2 EXHIBIT 99.1 e3674_ex99-1.htm EX-99.1 7719
  Complete submission text file 0001731122-22-000671.txt   204985

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE enob-20220405.xsd EX-101.SCH 2968
4 XBRL LABEL FILE enob-20220405_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE enob-20220405_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT e3674_8-k_htm.xml XML 3615
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 22805095
SIC: 2834 Pharmaceutical Preparations